Clostridium difficile infection epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) |
|||
| (7 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Clostridium difficile}} | {{Siren|Clostridium difficile infection}} | ||
{{Clostridium difficile infection}} | |||
{{CMG}}; {{AE}} {{YD}} | {{CMG}}; {{AE}} {{YD}} | ||
==Overview== | ==Overview== | ||
The incidence of ''C. difficile'' infection is estimated to be | The incidence of ''C. difficile'' infection is estimated to be 140 per 100,000 individuals. In USA, the majority (65%) of cases are associated with healthcare settings, and 25% of cases are associated with previous hospitalizations. Although patients of all age groups may develop ''C. difficile'' infection, elderly patients > 65 years may have up to eight-fold increased risk of developing ''C. difficile'' infection compared with younger patients. Whites and female patients are more predisposed to develop ''C. difficile'' infections. Although ''C. difficile'' is abundantly reported in Europe and the United States, the infection is a global burden. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
*The incidence of ''C. difficile'' infection is estimated to be | *The incidence of ''C. difficile'' infection is estimated to be 140 per 100,000 individuals and approximately 1,500 per 100,000 hospital discharges.<ref name="pmid25714160">{{cite journal| author=Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR et al.| title=Burden of Clostridium difficile infection in the United States. | journal=N Engl J Med | year= 2015 | volume= 372 | issue= 9 | pages= 825-34 | pmid=25714160 | doi=10.1056/NEJMoa1408913 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25714160 }} </ref> | ||
In the U.S. [[Veterans Affairs]] system, approximately 0.5% of admissions have c diff<ref name="pmid26864803">{{cite journal| author=Evans ME, Kralovic SM, Simbartl LA, Jain R, Roselle GA| title=Effect of a Clostridium difficile Infection Prevention Initiative in Veterans Affairs Acute Care Facilities. | journal=Infect Control Hosp Epidemiol | year= 2016 | volume= 37 | issue= 6 | pages= 720-2 | pmid=26864803 | doi=10.1017/ice.2016.27 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26864803 }} </ref><ref name="pmid31708000">{{cite journal| author=Sumon ZE, Lesse AJ, Sellick JA, Tetewsky S, Mergenhagen KA| title=Temporal trends of inpatient C. difficile infections within the Veterans Health Administration hospitals: An analysis of the effect of molecular testing, time to testing, and mandatory reporting. | journal=Infect Control Hosp Epidemiol | year= 2020 | volume= 41 | issue= 1 | pages= 44-51 | pmid=31708000 | doi=10.1017/ice.2019.281 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31708000 }} </ref>. | |||
===Age=== | ===Age=== | ||
| Line 16: | Line 19: | ||
===Race=== | ===Race=== | ||
* | *Caucasian individuals are more likely to develop ''C. difficile'' infection.<ref name="pmid25714160">{{cite journal| author=Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR et al.| title=Burden of Clostridium difficile infection in the United States. | journal=N Engl J Med | year= 2015 | volume= 372 | issue= 9 | pages= 825-34 | pmid=25714160 | doi=10.1056/NEJMoa1408913 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25714160 }} </ref> | ||
===Developed Countries=== | ===Developed Countries=== | ||
| Line 36: | Line 39: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Bacterial diseases]] | [[Category:Bacterial diseases]] | ||
Latest revision as of 02:29, 13 July 2020
|
C. difficile Infection Microchapters |
|
Differentiating Clostridium difficile infectionfrom other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Clostridium difficile infection epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Clostridium difficile infection epidemiology and demographics |
|
FDA on Clostridium difficile infection epidemiology and demographics |
|
CDC on Clostridium difficile infection epidemiology and demographics |
|
Clostridium difficile infection epidemiology and demographics in the news |
|
Blogs on Clostridium difficile infection epidemiology and demographics |
|
Risk calculators and risk factors for Clostridium difficile infection epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.
Overview
The incidence of C. difficile infection is estimated to be 140 per 100,000 individuals. In USA, the majority (65%) of cases are associated with healthcare settings, and 25% of cases are associated with previous hospitalizations. Although patients of all age groups may develop C. difficile infection, elderly patients > 65 years may have up to eight-fold increased risk of developing C. difficile infection compared with younger patients. Whites and female patients are more predisposed to develop C. difficile infections. Although C. difficile is abundantly reported in Europe and the United States, the infection is a global burden.
Epidemiology and Demographics
Incidence
- The incidence of C. difficile infection is estimated to be 140 per 100,000 individuals and approximately 1,500 per 100,000 hospital discharges.[1]
In the U.S. Veterans Affairs system, approximately 0.5% of admissions have c diff[2][3].
Age
- Patients of all age groups may develop C. difficile infection.
- Elderly patients > 65 years may have up to eight-fold increased risk of developing C. difficile infection compared with younger patients.[1]
Gender
- There is a slight female predisposition to the development of C. difficile infection with a female to male ratio of 1.26.[1]
Race
- Caucasian individuals are more likely to develop C. difficile infection.[1]
Developed Countries
- The estimated number of incident C. difficile infection in USA is estimated to be approximately range between approximately 397,000 and 508,500.[1]
- In USA, the majority (65%) of cases are associated with healthcare settings, and 25% of cases are associated with previous hospitalizations.[1]
- In USA, the NAP1 C. difficile strain is more common in healthcare settings than in community settings.
- In 2011, approximately 29,000 deaths have been attributed to C. difficile infection in USA.[1]
- Several C. difficile outbreaks have been reported in Canada, USA, and Europe.
Developing Countries
- Although C. difficile is abundantly reported in Europe and the United States, the infection is a global burden.
- The burden of C. difficile in developing countries is difficult to estimate due to scarcity of available data.
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR; et al. (2015). "Burden of Clostridium difficile infection in the United States". N Engl J Med. 372 (9): 825–34. doi:10.1056/NEJMoa1408913. PMID 25714160.
- ↑ Evans ME, Kralovic SM, Simbartl LA, Jain R, Roselle GA (2016). "Effect of a Clostridium difficile Infection Prevention Initiative in Veterans Affairs Acute Care Facilities". Infect Control Hosp Epidemiol. 37 (6): 720–2. doi:10.1017/ice.2016.27. PMID 26864803.
- ↑ Sumon ZE, Lesse AJ, Sellick JA, Tetewsky S, Mergenhagen KA (2020). "Temporal trends of inpatient C. difficile infections within the Veterans Health Administration hospitals: An analysis of the effect of molecular testing, time to testing, and mandatory reporting". Infect Control Hosp Epidemiol. 41 (1): 44–51. doi:10.1017/ice.2019.281. PMID 31708000.